Literature DB >> 14708938

Expression of nerve growth factor in human pancreatic beta cells.

Román Vidaltamayo1, Carlos M Mery, Arturo Angeles-Angeles, Guillermo Robles-Díaz, Marcia Hiriart.   

Abstract

Nerve growth factor (NGF) is an important modulator of rat pancreatic beta-cell physiology in vitro. In this study, we analysed the expression of NGF, TrkA and insulin in human pancreatic islets from normal, ductal adenocarcinoma and insulinoma-afflicted samples, using double immunofluorescent labelling and confocal microscopy. We found that in normal human pancreas, insulin and NGF are co-expressed in beta cells. Moreover, similar to previous observations in rat, the high affinity NGF receptor TrkA is also expressed in beta cells. Pancreatic beta cells in normal islets from adenocarcinoma and mucinous cystadenocarcinoma patients also expressed NGF. In 2 out of 15 exocrine tumour samples, NGF was detected also in the tissue surrounding the islets, while 2 out of 13 adenocarcinoma tumours expressed this growth factor. In five insulinoma samples, we observed weaker immunofluorescent labelling of insulin and NGF in the neoplastic tissue, compared to the islets not afflicted by the tumour, which may be a consequence of increased hormone secretion rate. We demonstrate that human beta cells express TrkA and NGF. These findings are consistent with the hypothesis that NGF modulates insulin secretion through a paracrine/autocrine loop, similar to the one observed in cultured rat beta cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14708938     DOI: 10.1080/08977190310001629566

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  7 in total

1.  Systemic Depletion of Nerve Growth Factor Inhibits Disease Progression in a Genetically Engineered Model of Pancreatic Ductal Adenocarcinoma.

Authors:  Jami L Saloman; Aatur D Singhi; Douglas J Hartman; Daniel P Normolle; Kathryn M Albers; Brian M Davis
Journal:  Pancreas       Date:  2018-08       Impact factor: 3.327

Review 2.  Nerve growth factor: a neuroimmune crosstalk mediator for all seasons.

Authors:  Stephen D Skaper
Journal:  Immunology       Date:  2017-02-21       Impact factor: 7.397

3.  Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells.

Authors:  Yuji Okada; Guido Eibl; Sushovan Guha; John P Duffy; Howard A Reber; Oscar J Hines
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

4.  Pancreatic neuro-insular network in young mice revealed by 3D panoramic histology.

Authors:  Shiue-Cheng Tang; Chia-Ning Shen; Pei-Yu Lin; Shih-Jung Peng; Hung-Jen Chien; Ya-Hsien Chou; Chester E Chamberlain; Pankaj J Pasricha
Journal:  Diabetologia       Date:  2017-09-01       Impact factor: 10.122

5.  Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy.

Authors:  B A Mysona; S Matragoon; M Stephens; I N Mohamed; A Farooq; M L Bartasis; A Y Fouda; A Y Shanab; D G Espinosa-Heidmann; A B El-Remessy
Journal:  Biomed Res Int       Date:  2015-03-17       Impact factor: 3.411

6.  Low-Molecular-Weight NGF Mimetic Corrects the Cognitive Deficit and Depression-like Behavior in Experimental Diabetes.

Authors:  R U Ostrovskaya; S S Yagubova; T A Gudasheva; S B Seredenin
Journal:  Acta Naturae       Date:  2017 Apr-Jun       Impact factor: 1.845

7.  Epidermal growth factor increases insulin secretion and lowers blood glucose in diabetic mice.

Authors:  H Y Lee; K Yea; J Kim; B D Lee; Y C Chae; H S Kim; D-W Lee; S-H Kim; J-H Cho; C J Jin; D-S Koh; K S Park; P-G Suh; S H Ryu
Journal:  J Cell Mol Med       Date:  2007-12-05       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.